How COVID-19 causes loss of smell
Why some die, some survive when equally ill from COVID-19
COVID-19 and blood clots
Vaccinated mothers pass antibodies to newborns
COVID-19 and neurological symptoms
How SARS-CoV-2 evades immune system defenses
Single-dose COVID-19 vaccine effective against variants, study says
A crucial aspect of Harvard’s COVID response was the creation of the Massachusetts Consortium on Pathogen Readiness. MassCPR includes scientists from Harvard, MIT, Boston University, Tufts University, the University of Massachusetts, and local hospitals, all united to fight COVID-19 and prepare for future epidemics.
Institutions receive MassCPR research funding.
Scientists involved in MassCPR.
COVID-19 patient specimens provided to investigators.
Current Harvard president gave blood to MassCPR.
Milligrams of SARS-CoV-2 spike protein produced and shared with scientists.
Hours in Zoom meetings.
Members of the Harvard community talk about successes and struggles as they respond to COVID-19.
We’ve essentially had to build a medical device company from scratch.”
Richard Novak, senior staff engineer at the Wyss Institute for Biologically Inspired Engineering
It’s not just coincidence that the people from my community are dying and other communities are faring much better.”
Silvia Huerta Lopez, third-year M.D.-Ph.D. student and co-founder of Quetzales de Salud
We’re beginning to understand that technology is a basic right. You cannot participate in society in the 21st century without access to it.”
Fernando M. Reimers, Ford Foundation Professor of the Practice in International Education
Creating this fundraiser has been a lesson in the power of channeling despair into action and hope.”
Shyamli Badgaiyan, Harvard Business School student
If you’re lonely, almost the last thing you want to do is reach out, but you have to make yourself.”
Karestan Koenen, professor of psychiatric epidemiology at the School of Public Health